Cell and Gene Therapy
Cell and gene therapy products offer the potential for transformative, genetics-based solutions for patients with diseases previously thought incurable. ImmunXperts, a Q² Solutions Company, develops custom in vitro assays to screen immunomodulatory properties of cell and gene therapy products like stem cells, DNA/mRNA constructs. These potency assays, such as mixed lymphocyte reactions, challenge biologics and reflect the mode of action. The resultant insights are crucial and fulfill regulatory requirements from preclinical phase toward late clinical phase and commercialization.